RHOA and gastric cancer: Yoon et al. confirmed that the combination of Rhoa pathway inhibition, 5-FU administration, and cisplatin therapy could decrease the proliferation and metastasis of GC cells to a greater extent than adjuvant chemotherapy monotherapy [95].